ENT TECH PTY LTD has a total of 14 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, Canada and Brazil. Its main competitors in its focus markets pharmaceuticals and medical technology are PARADIGM HEALTH SCIENCES PTY LTD, ACCU BREAK TECHNOLOGIES INC and MICRO ALGAE CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | Brazil | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Physical therapy devices |
# | Name | Total Patents |
---|---|---|
#1 | Barbalatt Sam | 12 |
#2 | Welford Mark Harold | 2 |
#3 | Sam Barbalatt | 1 |
Publication | Filing date | Title |
---|---|---|
CN108697731A | Composition for treating sinus disease and illness and method | |
AU2012212385A1 | Compositions and methods for the treatment of nasal passages |